GlassScriptPhysician profile
Michael Carrasquilla
NPI 1245724764
$1,146.72
in general payments reported to CMS, 2019-2025
11 companies · $197 in 2025
The $197 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $71.58 · 2022: $269 · 2023: $305 · 2024: $303 · 2025: $197.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $806.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $806.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioprotect Medical, INC. | $327.60 | 2024-2025 | Bioprotect Balloon Implant System |
| Novocure INC. | $164.66 | 2023 | Optune |
| Blue Earth Diagnostics | $133.98 | 2022-2023 | |
| Boston Scientific Corporation | $123.00 | 2024 | Spaceoar Vue System - 10ml |
| Pfizer INC. | $113.33 | 2019-2022 | |
| Progenics Pharmaceuticals, INC. | $112.75 | 2022-2023 | Pylarify |
| Sumitomo Pharma America, INC. | $80.88 | 2023-2024 | Orgovyx |
| Siemens Medical Solutions USA, INC. | $34.85 | 2025 | Varian Ethos Treatment Planning |
| Novartis Pharmaceuticals Corporation | $21.82 | 2019 | |
| Amgen INC. | $19.00 | 2019 | |
| Gilead Sciences, INC. | $14.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Carrasquilla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.